Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Conditions:   Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis Interventions:   Drug: NAC 900mg/day;   Drug: NAC 3600mg/day;   Drug: NAC 0mg/day (Placebo) Sponsors:   Weill Medical College of Cornell University;   National Institute of Neurological Disorders and Stroke (NINDS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2020 Category: Research Source Type: clinical trials